Annual Operating Profit
-$71.37 M
+$54.65 M+43.37%
31 December 2023
Summary:
Taysha Gene Therapies annual operaing income is currently -$71.37 million, with the most recent change of +$54.65 million (+43.37%) on 31 December 2023. During the last 3 years, it has fallen by -$28.37 million (-65.98%). TSHA annual operating profit is now -65.98% below its all-time high of -$43.00 million, reached on 31 December 2020.TSHA Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$21.06 M
+$239.00 K+1.12%
30 September 2024
Summary:
Taysha Gene Therapies quarterly operating income is currently -$21.06 million, with the most recent change of +$239.00 thousand (+1.12%) on 30 September 2024. Over the past year, it has dropped by -$5.43 million (-34.71%). TSHA quarterly operating profit is now -1788.79% below its all-time high of -$1.11 million, reached on 01 December 2019.TSHA Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$82.49 M
-$5.43 M-7.04%
30 September 2024
Summary:
Taysha Gene Therapies TTM operating income is currently -$82.49 million, with the most recent change of -$5.43 million (-7.04%) on 30 September 2024. Over the past year, it has dropped by -$9.36 million (-12.80%). TSHA TTM operating profit is now -7297.85% below its all-time high of -$1.11 million, reached on 01 December 2019.TSHA TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TSHA Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +43.4% | -34.7% | -12.8% |
| 3 y3 years | -66.0% | +58.5% | +41.9% |
| 5 y5 years | - | -1788.8% | -7297.9% |
TSHA Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -66.0% | +58.8% | -34.7% | +58.5% | -15.6% | +56.8% |
| 5 y | 5 years | -66.0% | +58.8% | -1788.8% | +58.5% | -7297.9% | +56.8% |
| alltime | all time | -66.0% | +58.8% | -1788.8% | +58.5% | -7297.9% | +56.8% |
Taysha Gene Therapies Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$21.06 M(-1.1%) | -$82.49 M(+7.0%) |
| June 2024 | - | -$21.30 M(-12.5%) | -$77.06 M(-2.6%) |
| Mar 2024 | - | -$24.33 M(+54.0%) | -$79.14 M(+10.9%) |
| Dec 2023 | -$71.37 M(-43.4%) | -$15.80 M(+1.0%) | -$71.37 M(-2.4%) |
| Sept 2023 | - | -$15.63 M(-33.1%) | -$73.12 M(-11.8%) |
| June 2023 | - | -$23.38 M(+41.2%) | -$82.95 M(-10.7%) |
| Mar 2023 | - | -$16.56 M(-5.6%) | -$92.94 M(-26.3%) |
| Dec 2022 | -$126.03 M | -$17.55 M(-31.1%) | -$126.03 M(-20.3%) |
| Sept 2022 | - | -$25.46 M(-23.7%) | -$158.21 M(-13.8%) |
| June 2022 | - | -$33.37 M(-32.8%) | -$183.43 M(-3.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$49.65 M(-0.1%) | -$190.83 M(+10.1%) |
| Dec 2021 | -$173.27 M(+302.9%) | -$49.72 M(-1.9%) | -$173.27 M(+22.1%) |
| Sept 2021 | - | -$50.68 M(+24.3%) | -$141.91 M(+33.5%) |
| June 2021 | - | -$40.77 M(+27.1%) | -$106.27 M(+52.9%) |
| Mar 2021 | - | -$32.09 M(+74.7%) | -$69.51 M(+61.6%) |
| Dec 2020 | -$43.00 M | - | - |
| Dec 2020 | - | -$18.37 M(+22.1%) | -$43.00 M(+67.0%) |
| Sept 2020 | - | -$15.04 M(+275.1%) | -$25.75 M(+140.5%) |
| June 2020 | - | -$4.01 M(-28.2%) | -$10.71 M(+59.9%) |
| Mar 2020 | - | -$5.58 M(+400.8%) | -$6.70 M(+500.8%) |
| Dec 2019 | - | -$1.11 M | -$1.11 M |
FAQ
- What is Taysha Gene Therapies annual operaing income?
- What is the all time high annual operating profit for Taysha Gene Therapies?
- What is Taysha Gene Therapies annual operating profit year-on-year change?
- What is Taysha Gene Therapies quarterly operating income?
- What is the all time high quarterly operating profit for Taysha Gene Therapies?
- What is Taysha Gene Therapies quarterly operating profit year-on-year change?
- What is Taysha Gene Therapies TTM operating income?
- What is the all time high TTM operating profit for Taysha Gene Therapies?
- What is Taysha Gene Therapies TTM operating profit year-on-year change?
What is Taysha Gene Therapies annual operaing income?
The current annual operating profit of TSHA is -$71.37 M
What is the all time high annual operating profit for Taysha Gene Therapies?
Taysha Gene Therapies all-time high annual operaing income is -$43.00 M
What is Taysha Gene Therapies annual operating profit year-on-year change?
Over the past year, TSHA annual operaing income has changed by +$54.65 M (+43.37%)
What is Taysha Gene Therapies quarterly operating income?
The current quarterly operating profit of TSHA is -$21.06 M
What is the all time high quarterly operating profit for Taysha Gene Therapies?
Taysha Gene Therapies all-time high quarterly operating income is -$1.11 M
What is Taysha Gene Therapies quarterly operating profit year-on-year change?
Over the past year, TSHA quarterly operating income has changed by -$5.43 M (-34.71%)
What is Taysha Gene Therapies TTM operating income?
The current TTM operating profit of TSHA is -$82.49 M
What is the all time high TTM operating profit for Taysha Gene Therapies?
Taysha Gene Therapies all-time high TTM operating income is -$1.11 M
What is Taysha Gene Therapies TTM operating profit year-on-year change?
Over the past year, TSHA TTM operating income has changed by -$9.36 M (-12.80%)